Luke P. Akard

Longitudinal Study of Adaptation to the Stress of Bone Marrow Transplantation

Betsy L. Fife, Gertrude A. Huster, Kenneth Cornetta et al. · Journal of Clinical Oncology · 2000 · 183 citations

Medicine, Psychology, Stem Cell Transplantation +12

High-Dose Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia: High Rates of Rapid Cytogenetic and Molecular Responses

Jörge E. Cortes, Hagop M. Kantarjian, Stuart L. Goldberg et al. · Journal of Clinical Oncology · 2009 · 125 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +11

Parsaclisib, a potent and highly selective PI3Kδ inhibitor, in patients with relapsed or refractory B-cell malignancies

Andres Forero‐Torres, Radhakrishnan Ramchandren, Abdulraheem Yacoub et al. · Blood · 2019 · 100 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +9

Effects of extensive splenomegaly in patients with myelofibrosis undergoing a reduced intensity allogeneic stem cell transplantation

Stefan O. Ciurea, Barry Sadegi, Andrew C. Wilbur et al. · British Journal of Haematology · 2008 · 66 citations

Medicine, Hematology, Immunology +14

Subcutaneous Omacetaxine Mepesuccinate in Patients With Chronic-Phase Chronic Myeloid Leukemia Previously Treated With 2 or More Tyrosine Kinase Inhibitors Including Imatinib

Jörge E. Cortes, Franck E. Nicolini, Meir Wetzler et al. · Clinical Lymphoma Myeloma & Leukemia · 2013 · 65 citations

Medicine, Oncology, Pharmacology +8